Aju Business Daily January 4, 2022
Park Sae-jin

SEOUL — A consortium led by Eone Diagnomics Genome Center, a South Korea-based healthcare company engaged in genetic analysis, will provide a DNA-based health prediction service in a metaverse platform to help business partners create new business models based on genomic big data. A beta service involving consortium partners is underway, with an official service to be launched as early as this year.

The project aims to move the real world step by step into the virtual world like a mirror. It is a fourth-generation social network service that combines reality and virtual reality to allows hundreds of millions of users to mingle together using avatars and enable various commercial transactions as well as social and economic activities such as...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Big Data, Metaverse/VR, Pharma / Biotech, Precision Medicine, Technology
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future
Opinion: Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more
Precision medicine approach combining AI, DNA and drug testing shows gains against relapsed childhood cancers

Share This Article